Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
Titel:
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
Auteur:
Lesterhuis, W. Joost Schreibelt, Gerty Scharenborg, Nicole M. Brouwer, H. Mary-lène H. Gerritsen, Marie-Jeanne P. Croockewit, Sandra Coulie, Pierre G. Torensma, Ruurd Adema, Gosse J. Figdor, Carl G. Vries, I. Jolanda M. de Punt, Cornelis J. A.